Furthermore, we found that mifepristone, when used al lower concentration, shows cytostatic effects, whereas at higher concentration, it shows lethal effects towards all ovarian cancer cell lines studied, triggering a caspase-associated apoptotic death mechanism regardless of their degree of sensitivity to cisplatin and apparent p53 genetic status. The gene discussed is TP53; the disease is ovarian carcinoma.